Printer Friendly

Human Genome Sciences obtains United States patent.

Human Genome Sciences, Inc. (Rockville, MD) has patented human G-protein chemokine receptor polypeptides and DNA (RNA) encoding such polypeptides and a procedure for producing such polypeptides by recombinant techniques. Also disclosed are methods for utilizing such polypeptides for identifying antagonists and agonists to such polypeptides and methods of using the agonists and antagonists therapeutically to treat conditions related to the underexpression and overexpression of the G-protein chemokine receptor polypeptides, respectively. Also disclosed are diagnostic methods for detecting a mutation in the G-protein chemokine receptor nucleic acid sequences and detecting a level of the soluble form of the receptors in a sample derived from a host. (US 7,160,546)
COPYRIGHT 2006 Biotech Patent News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2006 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:BIOTECH Patent News
Date:Dec 1, 2006
Previous Article:Asahi Breweries obtains United States patent.
Next Article:The General Hospital Corporation obtains United States patent.

Related Articles
Who owns indigenous peoples' DNA?
Zyomyx issued pioneering protein chip patent.
U.S. Genomics awarded pioneering patent.
Zyomyx announces issuance of third protein chip patent.
Mobious Genomics patents ultra high speed sequencing technology.
Human Genome Sciences obtains United States patent.
Lexicon granted exclusive license to Cellectis' homologous recombination technology.

Terms of use | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters